The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition
- DOI
- 10.15488/15690
- Published
- 2023
- Container
- Not recorded
- Publisher
- Washington, DC : ACS Publications
- Open access
- yes
Credibility signals
limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.15488/15690,
title = {The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition},
author = {Koller, Timm O. and Scheid, Ullrich and Kösel, Teresa and Herrmann, Jennifer and Krug, Daniel and Boshoff, Helena I. M. and Beckert, Bertrand and Evans, Joanna C. and Schlemmer, Jan and Sloan, Becky and Weiner, Danielle M. and Via, Laura E. and Moosa, Atica and Ioerger, Thomas R. and Graf, Michael and Zinshteyn, Boris and Abdelshahid, Maha and Nguyen, Fabian and Arenz, Stefan and Gille, Franziska and Siebke, Maik and Seedorf, Tim and Plettenburg, Oliver and Green, Rachel and Warnke, Anna-Luisa and Ullrich, Joachim and Warrass, Ralf and Barry, Clifton E. and Warner, Digby F. and Mizrahi, Valerie and Kirschning, Andreas and Wilson, Daniel N. and Müller, Rolf},
year = {2023},
doi = {10.15488/15690},
url = {https://doi.org/10.15488/15690}
}RIS
TY - JOUR TI - The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition AU - Koller, Timm O. AU - Scheid, Ullrich AU - Kösel, Teresa AU - Herrmann, Jennifer AU - Krug, Daniel AU - Boshoff, Helena I. M. AU - Beckert, Bertrand AU - Evans, Joanna C. AU - Schlemmer, Jan AU - Sloan, Becky AU - Weiner, Danielle M. AU - Via, Laura E. AU - Moosa, Atica AU - Ioerger, Thomas R. AU - Graf, Michael AU - Zinshteyn, Boris AU - Abdelshahid, Maha AU - Nguyen, Fabian AU - Arenz, Stefan AU - Gille, Franziska AU - Siebke, Maik AU - Seedorf, Tim AU - Plettenburg, Oliver AU - Green, Rachel AU - Warnke, Anna-Luisa AU - Ullrich, Joachim AU - Warrass, Ralf AU - Barry, Clifton E. AU - Warner, Digby F. AU - Mizrahi, Valerie AU - Kirschning, Andreas AU - Wilson, Daniel N. AU - Müller, Rolf PY - 2023 DO - 10.15488/15690 UR - https://doi.org/10.15488/15690 ER -
APA
O., K. T., Ullrich, S., Teresa, K., Jennifer, H., Daniel, K., M., B. H. I., Bertrand, B., C., E. J., Jan, S., Becky, S., M., W. D., E., V. L., Atica, M., R., I. T., Michael, G., Boris, Z., Maha, A., Fabian, N., Stefan, A., Franziska, G., Maik, S., Tim, S., Oliver, P., Rachel, G., Anna-Luisa, W., Joachim, U., Ralf, W., E., B. C., F., W. D., Valerie, M., Andreas, K., N., W. D., & Rolf, M. (2023). The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. https://doi.org/10.15488/15690
Source records
- datacite · retrieved 2026-09-26T01:11:27.151Z